Exploring Clinical Trial Experiences of People With Leiomyosarcoma

Power Life Sciences Inc.500 enrolled

Overview

Clinical study participation has historically been heavily biased toward specific demographics. Several people will be invited to enroll in this study so that it may collect a variety of data about leiomyosarcoma clinical trial experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal. People with leiomyosarcoma who are invited to take part in medical research will benefit from the analysis of the data.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Leiomyosarcoma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient has self-identified as planning to enroll in an interventional clinical trial * Patient has been diagnosed with leiomyosarcoma * Patient is a minimum of 18 years or older Exclusion Criteria: * Patient does not understand, sign, and return consent form * Inability to perform regular electronic reporting * Patient is pregnant * ECOG score of 4

Outcomes

Primary Outcomes

Number of patients who decide to enroll in an leiomyosarcoma clinical trial

Time frame: 3 months

Rate of patients who remain in leiomyosarcoma clinical trial to trial completion

Time frame: 12 months

Central Contacts

Michael B Gill

CONTACT

4159004227 bask@withpower.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.